Ginkgo Bioworks (NYSE:DNA) stock is falling on Friday after the cell programming company announced plans for a reverse split of its shares.Ginkgo Bioworks wants to enact a reverse stock split for DNA shares in the range of one-for-20 to one-for-40. This has it holding a shareholder meeting to get approval from investors for the reverse stock split.That meeting is set to take place on Aug. 14, 2024 at 4:00 pm Eastern Time. If shareholders approve the reverse stock split, it will be up to the board of directo ...